Breaking News Instant updates and real-time market news.

RAD

Rite Aid

$4.66

0.01 (0.22%)

, WFM

Whole Foods

$29.28

-0.08 (-0.27%)

07:36
03/10/17
03/10
07:36
03/10/17
07:36

Unusual call flow in option market yesterday

Notable call activity was cited Thursday in Rite Aid (RAD), Whole Foods (WFM), Potash (POT), ILG Inc (ILG), JetBlue (JBLU), STMicroelectronics (STM), Encana (ECA), Genworth (GNW), Hartford Financial (HIG), and WPX Energy (WPX).

RAD

Rite Aid

$4.66

0.01 (0.22%)

WFM

Whole Foods

$29.28

-0.08 (-0.27%)

POT

Potash

$17.40

0.49 (2.90%)

ILG

ILG

$18.22

-0.08 (-0.44%)

JBLU

JetBlue

$19.08

-0.305 (-1.57%)

STM

STMicroelectronics

$15.21

-0.38 (-2.44%)

ECA

Encana

$10.51

-0.01 (-0.10%)

GNW

Genworth

$3.98

-0.11 (-2.69%)

HIG

Hartford Financial

$49.29

0.79 (1.63%)

WPX

WPX Energy

$12.22

0.33 (2.78%)

  • 14

    Mar

  • 15

    Mar

  • 16

    Mar

  • 19

    Mar

RAD Rite Aid
$4.66

0.01 (0.22%)

01/30/17
LEER
01/30/17
NO CHANGE
LEER
Outperform
Walgreens Boots Alliance, Rite Aid transaction still in-process, says Leerink
Leerink analyst David Larsen notes that he has confirmed with Walgreens Boots Alliance (WBA) that the deal with Rite Aid (RAD) would only terminate if either party were to walk away, which would require a formal announcement. Therefore, the analyst believes "no news is good news," and that the transaction is still in-process and on track. He reiterates an Outperform rating on Walgreens Boots Alliance's shares.
01/20/17
EVER
01/20/17
NO CHANGE
EVER
Rite Aid could trade to $3.50 or below if deal is not completed, says Evercore ISI
Evercore ISI analyst Ross Muken believes Rite Aid (RAD) could have "massive" downside and would likely trade to $3.50 or below if the acquisition by Walgreens Boots Alliance (WBA) were not completed. For Walgreens, Muken said, if the deal is not completed, it would be a modest negative given the synergy potential and time committed to deal closure, but he expects Walgreen not to sit on the capital for very long and would look for a combination of share repurchases and additional M&A in the not-too-distant future.
01/20/17
01/20/17
NO CHANGE

Rite Aid-Walgreens deal closing 'way more likely than not,' says Cowen
After a Bloomberg article said that the FTC is concerned about the sale of Rite Aid (RAD) stores to Fred's (FRED) as a remedy to concerns about Walgreens' (WBA) takeover deal, Cowen analyst Charles Rhyee said that the report could reflect a split staff at FTC and the losing side making some noise or it could be a public negotiating tactic. Given the various paths forward, including litigation, Rhyee still thinks it is "way more likely than not" that this deal will ultimately close and views the weakness in Walgreens shares as a buying opportunity.
01/17/17
01/17/17
UPGRADE
Target $95

Outperform
AmerisourceBergen upgraded to Outperform at Leerink
As previously reported, Leerink analyst David Larsen upgraded AmerisourceBergen (ABC) to Outperform from Market Perform and raised his price target on the shares to $95 from $75. The analyst believes the odds of the Walgreens Boots Alliance (WBA)/Rite Aid (RAD) transaction going through have "increased substantially," and believes that the long-term partnership with Walgreens Boots Alliance will act as a positive driver for volumes. Long-term, Larsen believes that AmerisourceBergen will continue to benefit from growth in specialty, biosimilars, and generic launches, while recent commentary seems to indicate that generic deflation trends are moderating.
WFM Whole Foods
$29.28

-0.08 (-0.27%)

02/02/17
CLVD
02/02/17
NO CHANGE
CLVD
Whole Foods estimate lowered on softenting trends at Cleveland Research
01/20/17
01/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Aegis. 2. Alphabet (GOOG, GOOGL) and Facebook (FB) were resumed with an Overweight at Pacific Crest, while Twitter (TWTR) was resumed with a Sector Weight. 3. Costco (COST) coverage was resumed with a Buy at Stifel, while Wal-Mart (WMT) and Target (TGT) were resumed with a Hold. 4. Whole Foods (WFM) was initiated with a Market Perform, while Sprouts Farmers Markets (SFM) was initiated with an Outperform at William Blair. 5. CBS (CBS) was reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/17
FBCO
02/09/17
NO CHANGE
Target $36
FBCO
Outperform
Whole Foods price target lowered to $36 from $40 at Credit Suisse
Credit Suisse analyst Edward Kelly lowered his price target for Whole Foods to $36 from $40 following the company's mixed Q1 earnings update. The analyst reiterates an Outperform rating on the shares as he continues to see value in the brand, believes there is a path for improved performance over time, and likes the stock's risk/reward.
02/09/17
PIVT
02/09/17
NO CHANGE
Target $20
PIVT
Sell
Pivotal calls Whole Foods sales deceleration 'alarming'
Pivotal Research analyst Ajay Jain believes Whole Foods' sales are decelerating at an "alarming rate." The company's guidance reduction last night is the latest in a multi-year string of earnings setbacks, Jain tells investors in a post-earnings research note. He keeps a Sell rating on the shares with a $20 price target.
POT Potash
$17.40

0.49 (2.90%)

01/24/17
01/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tableau (DATA) upgraded to Buy from Neutral at Citi with analyst Walter Pritchard saying consensus estimates for fiscal 2017 look low. Revenue transition impacted numbers more than the Street realized in 2016, Pritchard tells investors in a research note. The analyst raised his price target for the shares to $64 from $50. 2. Agrium (AGU) upgraded to Outperform from Market Perform at Cowen, while CF Industries (CF), Mosaic (MOS), and Potash (POT) were upgraded to Market Perform from Underperform. 3. Calithera Biosciences (CALA) upgraded to Neutral from Sell at Citi with analyst Robyn Karnauskas citing her conversation with management. Management now appears more open to partnering, Karnauskas tells investors in a research note. 4. Home Bancshares (HOMB) upgraded to Buy from Hold at Sandler O'Neill. 5. Amicus (FOLD) upgraded to Outperform from Neutral at Baird with analyst Michael Ulz saying the company removed two overhangs by providing regulatory clarity for Galafold in the U.S. as well as a strengthening its balance sheet. Ulz raised his price target to $10 from $7 on Amicus shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/24/17
COWN
01/24/17
UPGRADE
Target $18
COWN
Market Perform
Potash upgraded to Market Perform from Underperform at Cowen
Cowen analysts Charles Neivert and Jeffrey Rossetti raised their Agricultural Chemicals industry view to neutral and upgraded their ratings on several stocks in the space, including Potash (POT), which they upgraded to Market Perform from Underperform. The analyst raised their price target on Potash shares to $18 from $15.
01/24/17
COWN
01/24/17
UPGRADE
Target $109
COWN
Outperform
Agrium upgraded to Outperform from Market Perform at Cowen
Cowen analysts Charles Neivert and Jeffrey Rossetti raised their Agricultural Chemicals industry view to neutral and upgraded their ratings on several stocks in the space, as they believe that investors have finally discounted most of the negative factors driving the ag shares. As part of their industry upgrade, Neivert and Rossetti upgraded Agrium (AGU) to Outperform from Market Perform and raised their price target on the shares to $109 from $93. They also upgraded Potash (POT), Mosaic (MOS) and CF Industries (CF), all to Market Perform from Underperform.
03/09/17
BMOC
03/09/17
NO CHANGE
BMOC
BMO Capital expects fertilizer stocks to give back gains
BMO Capital believes fertilizer sector is up on comments made by Belarusian President Lukashenko. who said he would cooperate with the Russians/Uralkali on potash again, but the organization would have to be based in Minsk/Belarus and Belarus wouldn't make any concessions. The firm's analyst said Lukashenko has said this many times before and this is nothing new and expects fertilizer names to give back today's gains when the market figures this out.
ILG ILG
$18.22

-0.08 (-0.44%)

01/30/17
JANY
01/30/17
INITIATION
Target $24
JANY
Buy
ILG initiated with a Buy at Janney Capital
01/31/17
01/31/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. T-Mobile (TMUS) was initiated with a Buy at Evercore ISI, while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 2. ViaSat (VSAT) initiated with an Outperform at William Blair. 3. Wyndham (WYN) initiated with a Neutral at Janney Capital. 4. ILG (ILG) initiated with a Buy at Janney Capital. 5. United Natural Foods (UNFI) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
JBLU JetBlue
$19.08

-0.305 (-1.57%)

01/27/17
01/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Whirlpool (WHR) downgraded to Neutral from Buy at Goldman with analyst Samuel Eisner saying "tough" pricing in North America and "stronger" raw material headwinds should limit margin expansion. The analyst sees some risk to Whirlpool's 2017 guidance, especially in the back half of the year, and cut his price target for the shares to $187 from $191. 2. JetBlue (JBLU) was downgraded to Hold from Buy at Argus and to Underperform from Peer Perform at Wolfe Research. 3. Weatherford (WFT) downgraded to Hold from Buy at Jefferies with analyst Brad Handler citing a challenging international landscape, "disappointing" free cash flow in 2016 and continued share dilution. The analyst lowered his price target for the shares to $6 from $7. 4. Graphic Packaging (GPK) downgraded to Buy from Conviction Buy at Goldman with analyst Brian Maguire saying shares have underperformed since the guidance cut in October due to weaker end markets, higher OCC costs, foreign exchange, inventory restocking, Hurricane Mathew, and inventory restocking. 5. 8point3 Energy (CAFD) was downgraded to Underperform from Market Perform at Avondale and to Neutral from Buy at Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/27/17
WOLF
01/27/17
DOWNGRADE
WOLF
Underperform
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
01/27/17
ARGS
01/27/17
DOWNGRADE
ARGS
Hold
JetBlue downgraded to Hold from Buy at Argus
Argus analyst David Coleman downgraded JetBlue to Hold due to valuation and rising costs. The analyst said shares have had a strong run over the past five years but fuels costs and other expenses are rising, and is less bullish on the earnings outlook.
01/25/17
JPMS
01/25/17
DOWNGRADE
Target $55
JPMS
Neutral
Southwest downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jamie Baker downgraded Southwest Airlines (LUV) to Neutral saying the shares look less attractive at $50. The analyst recommends swapping into JetBlue (JBLU), a stock he upgraded this morning to Overweight. Baker raised his price target for Southwest shares to $55 from $51.50.
STM STMicroelectronics
$15.21

-0.38 (-2.44%)

02/22/17
CHLM
02/22/17
NO CHANGE
Target $18
CHLM
Buy
STMicroelectronics to have 'substantial beat and raise' ahead, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss says STMicroelectronics (STM) remains one of his top names for 2017 as he believes the company will have "a substantial beat and raise" for both the September and December quarters with results well above current consensus. Moreover, the analyst believes STMicroelectronics is already producing and stockpiling ToF sensors for Apple's (AAPL) iPhone 8. Stoss reiterated a Buy rating on the stock and raised his price target on the shares to $18 from $15.
02/22/17
02/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) upgraded to Buy from Neutral at BofA/Merrill with analyst Robert Ohmes saying the U.S. strategy is working and risk/reward is favorable on e-commerce sales momentum. 2. Scorpio Tankers (STNG) upgraded to Buy from Hold at ABN Amro with analyst Glenn Lodden raising his price target for the shares to $7.50 from $4.30. 3. Parker-Hannifin (PH) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying her analysis suggests the company's synergy targets for the Clarcor (CLC) acquisition are "overly conservative." The analyst feels the deal "makes good strategic sense." She raised her price target for Parker-Hannifin shares to $173 from $146. 4. STMicroelectronics (STM) upgraded to Overweight from Equal Weight at Barclays with analyst Andrew Gardiner saying further market share and content gains will show during 2017. 5. Ecolab (ECL) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/23/17
CHLM
02/23/17
NO CHANGE
CHLM
Buy
Craig-Hallum sees Tesla Model 3 commentary as positive for STMicroelectronics
Craig-Hallum analyst Tony Stoss says the positive commentary from Tesla (TSLA) on Model 3 production, which is on track for July, is a positive read through for STMicroelectronics (STM) that he believes is shipping about $300 of content/car in SiC products into the Model 3. The math works to $18M in revenues for STMicroelectronics this year and if Tesla hits its production goal of 500,000 cars next year that would be $150M in revenues for STMicroelectronics in 2018, the analyst adds. He reiterates a Buy rating on STMicroelectronics' shares.
03/09/17
CHLM
03/09/17
NO CHANGE
CHLM
Buy
iPhone 8 may have STMicroelectronics facial recognition tech, says Craig-Hallum
Craig-Hallum notes there has been speculation that perhaps there will be component shortages preventing Apple (AAPL) from launching the iPhone 8 in late September. The speculation has surrounded finger print sensors, AMOLD panels and now 3D sensing components, the firm says, pointing out that most believe STMicroelectronics (STM) could have 2 sensors in iPhone 8. Furthermore, Craig-Hallum thinks the latter could have a new facial recognition technology in Apple's upcoming smartphone as well. The firm believes STMicroelectronics has already started to produce and stockpile parts for the Apple 8 and does not expect any issues on its side. Craig-Hallum notes that Samsung (SSNLF) officials have stated they will also put facial recognition in the upcoming Galaxy 8, which should be supplied by STMicroelectronics. The firm has a Buy rating on STMicroelectronics' shares.
ECA Encana
$10.51

-0.01 (-0.10%)

02/21/17
MITR
02/21/17
DOWNGRADE
MITR
Hold
Encana downgraded to Hold from Buy at GMP Securities
02/15/17
02/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) and ConAgra Brands (CAG) were initiated with Buy ratings at Deutsche Bank. The firm also initiated Campbell Soup (CPB), J.M. Smucker (SJM) General Mills (GIS), Hershey (HSY), Kellogg (K) and Mondelez (MDLZ) with a Hold, as well as Pinnacle Foods (PF), Hostess Brands (TWNK) and Snyder's Lance (LNCE) with a Buy. 2. MasterCard (MA) and Visa (V) initiated with Buy ratings at Loop Capital by analyst Joseph Vafi. 3. Bioverativ (BIVV) initiated with an Outperform rating and $56 price target at Leerink by analyst Jason Gerberry. 4. Encana (ECA) initiated with an Overweight at JPMorgan. The firm also reinstated Cheniere Energy (LNG) and Cheniere Energy Partners LP (CQH) with Overweight ratings. 5. Blueprint Medicines (BPMC) initiated with an Overweight at Morgan Stanley by analyst Andrew Berens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
03/09/17
ADAM
03/09/17
INITIATION
Target $14
ADAM
Buy
Encana initiated with a Buy at Canaccord
Canaccord Genuity analyst Dennis Fong started Encana with a Buy rating and $14 price target.
02/15/17
JPMS
02/15/17
INITIATION
Target $16
JPMS
Overweight
Encana initiated with an Overweight at JPMorgan
JPMorgan analyst Gabriel Daoud started Encana with an Overweight rating and $16 price target. The company's Permian and Montney assets should drive around 390% cash flow growth through 2021, the analyst contends.
GNW Genworth
$3.98

-0.11 (-2.69%)

11/11/16
COMP
11/11/16
UPGRADE
COMP
Buy
Genworth upgraded to Buy from Neutral at Compass Point
10/05/16
BTIG
10/05/16
DOWNGRADE
BTIG
Neutral
Genworth downgraded to Neutral from Buy at BTIG
BTIG analyst Mark Palmer downgrading Genworth Financial to Neutral and removed its price target of $5 citing valuation.
09/22/16
WELS
09/22/16
INITIATION
WELS
Market Perform
Genworth coverage resumed with a Market Perform at Wells Fargo
01/24/17
BTIG
01/24/17
NO CHANGE
BTIG
Neutral
BTIG says Genworth could be worth 'pennies' if deal falls through
BTIG analyst Mark Palmer finds it "exceedingly difficult" to play Genworth Financial shares from the long or the short side. The upside for the shares, assuming no other bidder emerges, is capped at $5.43, or the price offered by China Oceanwide, Palmer tells investors in a research note. The analyst's sum-of-the-parts analysis yields a $4.23 per share price for Genworth, which he notes assumes the intrinsic value of the subsidiaries being fully unlocked, which he says is "far from a given." Palmer believes the value of Genworth shares is within 15%, plus or minus, from current levels. Investors concerned about mark-to-market risk, however, "need to get comfortable with the notion that the stock could trade in pennies in the immediate aftermath of an announcement that the China Oceanwide deal had been nixed," Palmer cautions. He keeps a Neutral rating on the shares. The stock closed yesterday at $3.77.
HIG Hartford Financial
$49.29

0.79 (1.63%)

12/08/16
RBCM
12/08/16
UPGRADE
RBCM
Outperform
Hartford Financial upgraded to Outperform from Sector Perform at RBC Capital
01/06/17
FBCO
01/06/17
DOWNGRADE
FBCO
Neutral
Hartford Financial downgraded to Neutral from Outperform at Credit Suisse
01/06/17
FBCO
01/06/17
DOWNGRADE
Target $53
FBCO
Neutral
Hartford Financial downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse downgraded Hartford Financial to Neutral from Outperform and increased its price target to $53 from $51. Analyst Ryan Tunis said shares have rerated since the election, partially on optimism around a potential sale of the run-off life unit, Talcott. Tunis thinks potential tax refrom makes Hartford less likely to sell Talcott as getting rid of AMT would accelerate Hartford's ability to realize cash value of the nearly $2B of DTA from NOLs that reside in Talcott. Further, the analyst believes there are two or three quarters of net positive reserve activity are needed for the stock to discount the idea of improved underwriting, which is unlikely in 2017 following Hartford's announcement that there is further adverse development in auto coming in the fourth quarter.
12/09/16
RBCM
12/09/16
UPGRADE
RBCM
Outperform
Hartford Financial upgraded on 2017 outlook at RBC Capital
As noted earlier, RBC Capital upgraded Hartford to Outperform from Sector Perform. Analyst Mark Dwelle says that personal auto insurance rate hikes should boost the company's margins next year, while its commercial business should continue to be "solid" and have growth potential. Target to $54 from $46.
WPX WPX Energy
$12.22

0.33 (2.78%)

01/30/17
DRXL
01/30/17
NO CHANGE
Target $22
DRXL
Buy
WPX Energy price target raised to $22 from 11 at Drexel Hamilton
Drexel Hamilton analyst Robert Christensen raised WPX Energy's price target to $22 from $11 given its high quality Permian focus. The analyst sees tremendous oil growth potential in WPX, probably 30% in 2017, 50% in 2018, and 20% thereafter through 2020. Christensen said the Permian basin is the "hottest oil play" on the planet right now and a potential acquisition of WPX would provide great Permian assets for nearly half the price.
11/28/16
DBAB
11/28/16
UPGRADE
Target $17
DBAB
Buy
WPX Energy upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Josh Silverstein upgraded WPX Energy to Buy citing valuation and the company's margin improvement. The analyst raised his price target for the shares to $17 from $15.
12/12/16
RHCO
12/12/16
NO CHANGE
RHCO
WPX Energy price target raised to $20 from $15 at SunTrust
SunTrust analyst Neal Dingmann says that upcoming increased drilling by WPX will enable the company to exploit higher commodity prices and improved efficiencies. The analyst raised his estimates for the company and keeps a Buy rating on the stock.
12/13/16
12/13/16
NO CHANGE

Baird sees Aramco IPO as reason for Saudis to follow through on cuts
Baird's energy research team, headed by Ethan Bellamy, Daniel Katzenberg, and Michael Gaiden, note Saudi Arabia is prepping the crude oil market for the floatation of the largest publicly traded company in history, Saudi Aramco, and they believe the Kingdom will follow through and balance the market in January as the "long-term payoff of that pricing exceeds a few quarters of production curtailment." Given that view, the firm recommends buying oil and oil-linked names and holding them through the deal, identifying Carrizo Oil & Gas (CRZO), WPX Energy (WPX) and Whiting Petroleum (WLL), Plains All American (PAA) and Plains GP Holdings (PAGP) as names to own based on their year-to-date correlations to oil.

TODAY'S FREE FLY STORIES

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PEP

PepsiCo

$117.91

0.38 (0.32%)

17:30
05/26/17
05/26
17:30
05/26/17
17:30
Periodicals
PepsiCo in talks to acquire Vita Coco owner All Market, Reuters reports »

PepsiCo is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$6.25

0.25 (4.17%)

17:25
05/26/17
05/26
17:25
05/26/17
17:25
Hot Stocks
Breaking Hot Stocks news story on Brightcove »

ESW Capital reports 8.08%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

SHIP

Seanergy Marine

$0.69

0.001244 (0.18%)

17:19
05/26/17
05/26
17:19
05/26/17
17:19
Hot Stocks
Seanergy Marine receives Nasdaq notice »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.93

0.07 (0.64%)

, DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

17:10
05/26/17
05/26
17:10
05/26/17
17:10
General news
S&P advances to end week at record as Fed signals no rush to normalize policy »

The S&P 500 (SPX)…

F

Ford

$10.93

0.07 (0.64%)

DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

BBY

Best Buy

$58.97

-2.28 (-3.72%)

HPQ

HP Inc.

$18.47

0.1 (0.54%)

BX

Blackstone

$32.58

0.11 (0.34%)

NOK

Nokia

$6.38

-0.02 (-0.31%)

AAPL

Apple

$153.61

-0.26 (-0.17%)

GM

General Motors

$33.07

0.47 (1.44%)

HUN

Huntsman

$24.75

-0.11 (-0.44%)

BF.A

Brown-Forman, also tag with BFA, BFB

$52.49

-0.21 (-0.40%)

BF.B

Brown-Forman, also tag with BFA, BFB

$51.73

0.13 (0.25%)

STZ

Constellation Brands

$180.93

0.79 (0.44%)

LOW

Lowe's

$80.91

-0.42 (-0.52%)

TIF

Tiffany

$86.18

0.36 (0.42%)

SHLD

Sears

$7.78

-0.7 (-8.25%)

SIG

Signet Jewelers

$49.31

-0.99 (-1.97%)

COST

Costco

$177.86

3.13 (1.79%)

ANF

Abercrombie & Fitch

$13.22

-0.83 (-5.91%)

AEO

American Eagle

$11.50

0.08 (0.70%)

EXPR

Express

$7.85

0.03 (0.38%)

TTWO

Take-Two

$77.07

-1.46 (-1.86%)

AZO

AutoZone

$615.62

8.28 (1.36%)

DSW

DSW

$16.73

-0.06 (-0.36%)

INTU

Intuit

$138.56

0.2 (0.14%)

PBYI

Puma Biotechnology

$79.75

1.7 (2.18%)

CHS

Chico's

$9.37

-0.39 (-4.00%)

SPLS

Staples

$8.98

-0.08 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

  • 21

    Jul

BGNE

BeiGene

$37.42

-0.04 (-0.11%)

17:07
05/26/17
05/26
17:07
05/26/17
17:07
Syndicate
Breaking Syndicate news story on BeiGene »

BeiGene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CGI

Celadon Group

17:06
05/26/17
05/26
17:06
05/26/17
17:06
Hot Stocks
Breaking Hot Stocks news story on Celadon Group »

Litespeed Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRD

Crawford & Company Inc.

, CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

17:05
05/26/17
05/26
17:05
05/26/17
17:05
Hot Stocks
Crawford & Company COO Robinson to leave company »

Crawford & Company…

CRD

Crawford & Company Inc.

CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

CRDB

Crawford & Company

$9.08

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$18.08

-0.13 (-0.71%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Hot Stocks
Breaking Hot Stocks news story on SeaWorld »

Hill Path Capital raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMRC

Digimarc

$36.10

2.45 (7.28%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Syndicate
Breaking Syndicate news story on Digimarc »

Digimarc files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 06

    Sep

IPCI

Intellipharmaceutics

$1.94

-0.01 (-0.51%)

17:01
05/26/17
05/26
17:01
05/26/17
17:01
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GWR

Genesee & Wyoming

$66.47

0.91 (1.39%)

16:57
05/26/17
05/26
16:57
05/26/17
16:57
Hot Stocks
Genesee & Wyoming CEO Hellmann named chairman of the board »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$1.61

0.02 (1.26%)

16:54
05/26/17
05/26
16:54
05/26/17
16:54
Syndicate
Breaking Syndicate news story on Paramount Gold Nevada »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

16:53
05/26/17
05/26
16:53
05/26/17
16:53
Syndicate
Breaking Syndicate news story on Sangamo »

Sangamo files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on TG Therapeutics »

TG Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

AVXL

Anavex

$5.88

-0.06 (-1.01%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on Anavex »

Anavex files to sell 5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.